Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial.
CNS Drugs March 24, 2026 Peer reviewed DOI: 10.1007/s40263-025-01250-z via PubMed Central
Abstract
Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial.